Najnowsze wersje próbne

EudraCT Number: 2022-003922-27

Sponsor Protocol Number: PAM-UMCG-002

Start Date: 2024-02-08

Sponsor Name: University Medical Center Groningen (UMCG)

Full Title: Neo-adjuvant Pembrolizumab as alternative to radio(chemo)therapy in MMRd uterine cancer

Medical condition: Primary uterine cancer characterized with dMMR

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-004238-20

Sponsor Protocol Number: CC21000

Start Date: 2024-02-06

Sponsor Name: Vejle Hospital

Full Title: BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung disease

Medical condition: COPD

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10042613 - Surgical and medical procedures	10075530	Medical cannabis therapy	PT
	21.1	10038738 - Respiratory, thoracic and mediastinal disorders	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2013-000356-18

Sponsor Protocol Number: 25051974

Start Date: 2023-12-21

Sponsor Name: Stichting Apotheek der Haarlemse Ziekenhuizen

Full Title: Effect of repeated intranasal cobalamin administration on cobalamin deficiency in elderly

Medical condition: Cobalamin (vitamin B12) deficiency

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: NL (Completed)

Trial results: (No results available)

EudraCT Number: 2020-003146-36

Sponsor Protocol Number: RIAlta-1

Start Date: 2023-11-15

Sponsor Name: Vall d'Hebron Research Institute (VHIR)

Full Title: Safety of Rifampicin at High Dose for the Treatment of Adult Subjects with Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis

Medical condition: Pulmonary and extrapulmonary tuberculosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-003804-15

Sponsor Protocol Number: SGMCBM

Start Date: 2023-11-09

Sponsor Name: Leiden University Medical Center

Full Title: A FEASIBILITY STUDY OF SGM-101, A FLUOROCHROME-LABELED ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY FOR THE INTRAOPERATIVE DETECTION OF COLORECTAL BRAIN METASTASES

Medical condition: Colorectal brain metastases

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10055093	Brain cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001632-28

Sponsor Protocol Number: GENTLE

Start Date: 2023-10-24

Sponsor Name: Rijnstate

Full Title: Ghrelin in anterior circulation stroke and EVT

Medical condition: acute ischemic stroke

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-004049-19

Sponsor Protocol Number: NL77938.018.23

Start Date: 2023-10-13

Sponsor Name: Amsterdam UMC

Full Title: Sodium oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study.

Medical condition: Catatonia in patients with depression, bipolar disorder or a psychotic disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-003318-35

Sponsor Protocol Number: VX22-264-101

Start Date: 2023-09-25

Sponsor Name: Vertex Pharmaceuticals Incorporated

Full Title: A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-264 in Subjects With Type 1 Diabetes Mellitus

Medical condition: Type 1 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10012601	Diabetes mellitus	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Ongoing) NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-001287-10

Sponsor Protocol Number: NBK241/2/2022

Start Date: 2023-09-22

Sponsor Name: Gdański Uniwersytet Medyczny

Full Title: Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS

Medical condition: acute ischemic stroke caused by occlusion of a large vessel

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.1	10029205 - Nervous system disorders	10084836	Malignant ischemic stroke	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2022-002839-66

Sponsor Protocol Number: IMVT-1401-3203

Start Date: 2023-09-07

Sponsor Name: Immunovant Sciences, GmbH

Full Title: An Open-label Extension Study for Participants who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)

Medical condition: Thyroid Eye Disease (TED)

Disease:	Version	SOC Term	Classification Code	Term	Level
	23.1	100000004853	10084358	Thyroid eye disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Not Authorised) LV (Ongoing) BE (Trial now transitioned) HU (Ongoing) SK (Trial now transitioned) IT (Ongoing) ES (Ongoing) PL (Ongoing)

Trial results: (No results available)

Najnowsze wersje próbne

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe